Skip to main content

Table 2 The univariate and multivariate analysis of lncRNA-AC079061.1 and clinicopathological features of HCC patients

From: lncRNA-AC079061.1/VIPR1 axis may suppress the development of hepatocellular carcinoma: a bioinformatics analysis and experimental validation

Characteristics

Total(N)

Univariate analysis

Multivariate analysis

Hazard ratio (95% CI)

P value

Hazard ratio (95% CI)

P value

T stage

370

    

 T1 & T2

277

Reference

   

 T3 & T4

93

2.598 (1.826–3.697)

< 0.001 

2.026 (0.274–14.988)

0.489

N stage

258

    

 N0

254

Reference

   

 N1

4

2.029 (0.497–8.281)

0.324

  

M stage

272

    

 M0

268

Reference

   

 M1

4

4.077 (1.281–12.973)

0.017

1.581 (0.478–5.230)

0.453

Pathologic stage

349

    

 Stage I & Stage II

259

Reference

   

 Stage III & Stage IV

90

2.504 (1.727–3.631)

 < 0.001

1.412 (0.192–10.368)

0.734

Histologic grade

368

    

 G1 & G2

233

Reference

   

 G3 & G4

135

1.091 (0.761–1.564)

0.636

  

Gender

373

    

 Female

121

Reference

   

 Male

252

0.793 (0.557–1.130)

0.200

  

Age

373

    

  ≤ 60

177

Reference

   

  > 60

196

1.205 (0.850–1.708)

0.295

  

Vascular invasion

317

    

 No

208

Reference

   

 Yes

109

1.344 (0.887–2.035)

0.163

  

AC079061 1

373

    

 Low

186

Reference

   

 High

187

0.630 (0.444–0.893)

0.010

0.573 (0.365–0.899)

0.015